Total Funding
86
87
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
18631
clinical-stage biotechnology company discovering & developing targeted therapies with disruptive safety and efficacy.
About the Company
RS Research is a clinical-stage biotech company advancing Sagitta® smart nanomedicines and clinically validated polymer-drug conjugates for targeted chemotherapy, disrupting the efficacy-toxicity trade-off. Phase 1 validation, Phase 2 readiness, European Medicines Agency SME status and in-house GMP signal near-term milestones and a scarce,
high-upside opportunity, with a rich pipeline and multiple candidates advancing. Lead asset RS-0139 is approaching end of Phase 1b with markedly improved hematologic safety vs conventional chemo as well as promising efficacy signs.
Women Founded
Women Led
